Life Sciences
Haydale Graphene Industries plc
Year
2023
Transaction type Equity Capital Markets & Corporate Broking
Sector Life Sciences
Cavendish is delighted to have acted as nominated adviser and broker in connection with Haydale Graphene Industries plc recent £5.1 m fundraising.
Haydale is a leading global technology solutions company that specialises in the design, development, and commercialisation of advanced materials using graphene and other nanomaterials.
Julian Blunt, Corporate Finance Director at Cavendish, commented:
“We are pleased to have raised the funds to allow Haydale to continue to develop the ongoing commercialisation of its proprietary HDPlas® plasma functionalisation process”.